- Report
- March 2025
- 187 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 244 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 147 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- November 2024
- 203 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- July 2024
- 189 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- January 2024
- 269 Pages
Global
From €6617EUR$7,525USD£5,481GBP
- Report
- August 2022
- 116 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- July 2021
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- December 2023
- 272 Pages
Global
€4546EUR$4,995USD£3,897GBP
- Report
- February 2024
- 85 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2023
- 497 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Report
- February 2021
- 181 Pages
Europe
From €3378EUR$3,712USD£2,896GBP
- Book
- October 2019
- 720 Pages
- Book
- November 2011
- 224 Pages
The Quinolone market is a subset of the Antibiotics market, which is composed of drugs used to treat bacterial infections. Quinolones are a class of antibiotics that are used to treat a wide range of bacterial infections, including respiratory, urinary tract, and skin infections. They are generally well-tolerated and have a broad spectrum of activity, making them a popular choice for treating bacterial infections. Quinolones are available in both oral and intravenous formulations, and are often used in combination with other antibiotics.
Quinolones are widely used in both the hospital and outpatient settings, and are often prescribed for long-term use. They are also used in the treatment of certain types of cancer, such as leukemia and lymphoma.
Some of the major companies in the Quinolone market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Sanofi. Show Less Read more
